20-31996592-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001011718.2(XKR7):c.875G>A(p.Arg292Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00036 in 1,547,904 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001011718.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XKR7 | NM_001011718.2 | c.875G>A | p.Arg292Gln | missense_variant | 3/3 | ENST00000562532.3 | NP_001011718.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XKR7 | ENST00000562532.3 | c.875G>A | p.Arg292Gln | missense_variant | 3/3 | 1 | NM_001011718.2 | ENSP00000477059 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 151924Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000175 AC: 35AN: 200394Hom.: 0 AF XY: 0.000195 AC XY: 21AN XY: 107466
GnomAD4 exome AF: 0.000374 AC: 522AN: 1395862Hom.: 1 Cov.: 33 AF XY: 0.000346 AC XY: 238AN XY: 688122
GnomAD4 genome AF: 0.000237 AC: 36AN: 152042Hom.: 0 Cov.: 31 AF XY: 0.000256 AC XY: 19AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2021 | The c.875G>A (p.R292Q) alteration is located in exon 3 (coding exon 3) of the XKR7 gene. This alteration results from a G to A substitution at nucleotide position 875, causing the arginine (R) at amino acid position 292 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at